Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Terminated × Vigabatrin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1 Seizures 1

Interventions

Saline Solution 6 Fentanyl 6 Sodium Chloride 5 Letrozole 5 Pregabalin 4 Ketamine 4 Goserelin 4 Gemcitabine 4 Dexamethasone 4 Bevacizumab 4 Tranexamic Acid 3 Photochemotherapy 3 Pemetrexed 3 Paclitaxel 3 Metformin 3 Leuprolide 3 Docetaxel 3 Cyclophosphamide 3 Carboplatin 3 Capecitabine 3 Acetaminophen 3 ulipristal acetate 2 sodium glycididazole 2 nilotinib 2 liposomal doxorubicin 2 human papillomavirus vaccine, L1 type 16, 18 2 flurbiprofen axetil 2 fludarabine 2 fluciclovine F-18 2 epoetin beta 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01266291 2017-07-12

STARS

University of Pennsylvania

Phase 4 Terminated

1 enrolled 8 charts

Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡